glp 1 for weight management GLP-1 Medications Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Long-term Success of GLP-1s Hinges

AC has received consulting or speaker fees from Bristol Meyer Squibb, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo-Nordisk, Sanofi-Aventis, Sigma-Tau, Takeda

The highest dose of Zepbound, Eli Lillys injectable GLP-1 drug approved for obesity management, leads to a 21% weight loss in adults without diabetes after 72 weeks, according to the company

That translates to roughly 56 lb for someone starting at 231 lb

Allergens / Allergen information: This product is manufactured in a plant that processes ingredients containing gluten, milk, corn, soya, oats, wheat, egg, celery, mustard, sulphites, fish, crustaceans, peanut and nut products

It retains the same two targets as tirzepatide but adds a critical third lever: GLP-1 Receptor Agonism: Drives central fullness and slows digestion